Synapse - Early Drug Development Service

Results (461)

Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms

Journal Article

Durham, B. H.; Lopez Rodrigo, E.; Picarsic, J.; Abramson, D.; Rotemberg, V.; De Munck, S.; Pannecoucke, E.; Lu, S. X.; Pastore, A.; Yoshimi, A.; more...
Nature Medicine (2019)

Fulltext@MSK | Save

Impact of FDG PET imaging for expanding patient eligibility and measuring treatment response in a genome-driven basket trial of the Pan-HER kinase inhibitor, neratinib

Journal Article

Ulaner, G. A.; Saura, C.; Piha-Paul, S. A.; Mayer, I.; Quinn, D.; Jhaveri, K.; Stone, B.; Shahin, S.; Mann, G.; Dujka, M.; more...
Clinical Cancer Research (2019)

Fulltext@MSK | Save

Foreword

Editorial

Hyman, D. M.; Ladanyi, M.
Annals of Oncology (2019)

Fulltext@MSK | Save

Molecular characteristics, immunophenotype, and immune checkpoint inhibitor response in BRAF non-V600 mutant lung cancers

Meeting Abstract

Offin, M.; Pak, T.; Mondaca, S.; Montecalvo, J.; Rekhtman, N.; Halpenny, D.; Wu, S.; Kris, M.; Paik, P.; Riely, G.; more...
Journal of Thoracic Oncology (2019)

Fulltext@MSK | Save

Generation and characterization of novel preclinical disease models of NSCLC with NRG1 rearrangements to improve therapy

Meeting Abstract

Gladstone, E.; Vojnic, M.; Offin, M.; Delasos, L.; Lui, A.; Siau, E.; Sato, H.; Benayed, R.; Kurth, R.; Mattar, M.; more...
Journal of Thoracic Oncology (2019)

Fulltext@MSK | Save

Activity of larotrectinib in TRK fusion lung cancer

Meeting Abstract

Farago, A.; Kummar, S.; Moreno, V.; Patel, J.; Lassen, U.; Rosen, L.; Ku, N.; Cox, M.; Nanda, S.; Childs, B.; more...
Journal of Thoracic Oncology (2019)

Fulltext@MSK | Save

Integrated germline and somatic analysis identifies actionable cancer predisposing germline mutations in 9,734 patients with advanced cancers

Meeting Abstract

Jayakumaran, G.; Mandelker, D.; Birsoy, O.; Jairam, S.; Li, Y.; Yang, C.; Somar, J.; Rai, V.; Syed, A.; Benayed, R.; more...
Journal of Molecular Diagnostics (2019)

Fulltext@MSK | Save

Growth modulation index (GMI) as a comparative measure of clinical activity of larotrectinib versus prior systemic treatments in adult and pediatric TRK fusion cancer patients

Meeting Abstract

Italiano, A.; Nanda, S.; Keating, K.; Childs, B. H.; Fellous, M.; Drilon, A.; Hyman, D. M.
Annals of Oncology (2019)

Fulltext@MSK | Save

Durability of response with larotrectinib in adult and pediatric patients with TRK fusion cancer

Meeting Abstract

Hyman, D. M.; Tan, D. S. W.; van Tilburg, C. M.; Albert, C. M.; Geoerger, B.; Farago, A. F.; Laetsch, T. W.; Kummar, S.; Doz, F.; Lassen, U. N.; more...
Annals of Oncology (2019)

Fulltext@MSK | Save

A phase II basket study of MCLA-128, a bispecific antibody targeting the HER3 pathway, in NRG1 fusion-positive advanced solid tumours

Meeting Abstract

Schram, A. M.; Drilon, A.; Macarulla Mercade, T.; O'Reilly, E. M.; Rodon, J. A.; Wolpin, B. M.; Ou, S. H. I.; Kim, D. W.; Yang, J. C. H.; Lam, Y. C. J.; more...
Annals of Oncology (2019)

Fulltext@MSK | Save